SELVAS Healthcare (208370)

Ticker: 208370 Exchange: KOREA


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Yoo Byung Tak (유병탁) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
350.42
Quantity 96,741 +12.9%
Value ₩726,914
Lee hae seok (이해석) Director (이사) Director
Transaction date
Purchase
Price
339.31
Quantity 83,981 -25.7%
Value ₩1,026,605
Kim iL Hyung (김일형) Director (이사) Director
Transaction date
Purchase
Price
118.07
Quantity 39,796 -24.2%
Value ₩2,006,765
Yoo Byung Tak (유병탁) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
5,024.00
Quantity 4,951 +77.6%
Value ₩24,873,824
Kweon Cheol Jung (권철중) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
4,909.00
Quantity 13,623 +213.6%
Value ₩66,875,307
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2017-06-23 2017-06-19 B Purchase Yoo Byung Tak (유병탁)

Representative Director (대표이사)

Executive Director
96,741 +12.9%
350.42
₩726,914
96,741 +12.9% 350.42 ₩726,914
2017-06-23 2017-06-19 B Purchase Lee hae seok (이해석)

Director (이사)

Director
83,981 -25.7%
339.31
₩1,026,605
83,981 -25.7% 339.31 ₩1,026,605
2017-06-23 2017-06-19 B Purchase Kim iL Hyung (김일형)

Director (이사)

Director
39,796 -24.2%
118.07
₩2,006,765
39,796 -24.2% 118.07 ₩2,006,765
2017-04-19 2017-04-12 B Purchase Yoo Byung Tak (유병탁)

Representative Director (대표이사)

Executive Director
4,951 +77.6%
5,024.00
₩24,873,824
4,951 +77.6% 5,024.00 ₩24,873,824
2017-04-10 2017-04-04 B Purchase Kweon Cheol Jung (권철중)

Representative Director (대표이사)

Executive Director
13,623 +213.6%
4,909.00
₩66,875,307
13,623 +213.6% 4,909.00 ₩66,875,307
Explore more

More insider trading research around SELVAS Healthcare